Abstract

PSY44 A Cost Effectiveness Model for the Myeloplastic Disease in Greece. Azacitidine Versus Conventional Care Regimens

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece.
George Gourzoulidis ... Giannis Papageorgiou
Drug Investigation | VOL. 41
George Gourzoulidis, et. al.George Gourzoulidis ... Giannis Papageorgiou
09 Mar 2021
CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece.
Gianni Ghetti ... Giannis Papageorgiou
ClinicoEconomics and Outcomes Research | VOL. 15
Gianni Ghetti, et. al.Gianni Ghetti ... Giannis Papageorgiou
01 Feb 2023
Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with >30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study
Hartmut Döhner ...
Blood | VOL. 124
Hartmut Döhner, et. al.Hartmut Döhner ...
06 Dec 2014
Efficacy and Safety of Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Patients Aged ≥75 Years with Acute Myeloid Leukemia (AML) in the Phase 3 AZA-AML-001 Study
John F Seymour ... Hervé Dombret
Blood | VOL. 128
John F Seymour, et. al.John F Seymour ... Hervé Dombret
02 Dec 2016
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
View more papers